Agenus (AGEN)

Agenus on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).

Download CSV

7.0M

Short interest

settlement 2026-10-15

6.5

Days to cover

+0.8 days vs prior

61.6%

Short share of volume

2026-11-02

Fails to deliver

settlement 2026-09-23

Mon 9 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in AGEN is 7,002,898 shares, up 199,212 shares over the last month. Over the last 48 readings it ranged from 1,772,528 shares (28 November 2025) to 7,057,525 shares (15 July 2026). The latest reading sits at the top of that range. At the reported average volume of 1.1M shares a day that is 6.5 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/agen" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	7,002,898	+2.7%	1,079,113	6.49
2026-09-30	6,818,562	+0.2%	1,205,674	5.66
2026-09-15	6,803,686	+1.7%	885,709	7.68
2026-08-31	6,689,181	+14.1%	1,096,999	6.10
2026-08-14	5,863,005	-5.9%	1,495,759	3.92
2026-07-31	6,232,820	-11.7%	2,045,159	3.05
2026-07-15	7,057,525	+17.7%	18,443,351	1.00
2026-06-30	5,994,778	+25.5%	1,105,541	5.42
2026-06-15	4,777,994	-12.6%	574,784	8.31
2026-05-29	5,464,046	+2.8%	660,410	8.27
2026-05-15	5,316,189	+21.2%	874,678	6.08
2026-04-30	4,387,571	+0.9%	923,680	4.75
2026-04-15	4,347,219	+1.5%	1,419,961	3.06
2026-03-31	4,284,092	+3.2%	545,507	7.85
2026-03-13	4,149,771	-1.1%	483,430	8.58
2026-02-27	4,197,067	-0.1%	294,807	14.24
2026-02-13	4,202,076	+8.4%	446,843	9.40
2026-01-30	3,875,294	+11.4%	771,904	5.02
2026-01-15	3,478,963	+2.4%	1,046,130	3.33
2025-12-31	3,399,217	+22.5%	715,032	4.75
2025-12-15	2,774,043	+56.5%	536,401	5.17
2025-11-28	1,772,528	-0.9%	384,439	4.61
2025-11-14	1,789,317	-6.1%	557,323	3.21
2025-10-31	1,904,780	-2.0%	474,781	4.01
2025-10-15	1,943,316	-12.2%	417,130	4.66
2025-09-30	2,213,459	-12.1%	473,636	4.67
2025-09-15	2,518,268	-6.8%	435,835	5.78
2025-08-29	2,703,058	+6.4%	344,252	7.85
2025-08-15	2,539,901	+0.9%	617,933	4.11
2025-07-31	2,517,300	+11.2%	827,335	3.04
2025-07-15	2,263,560	-11.1%	1,856,007	1.22
2025-06-30	2,545,292	-20.8%	1,087,878	2.34
2025-06-13	3,214,720	-16.8%	2,384,697	1.35
2025-05-30	3,865,104	-5.3%	746,623	5.18
2025-05-15	4,079,317	+0.6%	779,867	5.23
2025-04-30	4,053,860	-1.9%	1,212,517	3.34
2025-04-15	4,132,677	+9.6%	389,005	10.62
2025-03-31	3,769,274	+3.8%	489,211	7.70
2025-03-14	3,629,990	+12.6%	473,433	7.67
2025-02-28	3,225,183	+5.3%	328,415	9.82
2025-02-14	3,062,361	+4.6%	399,057	7.67
2025-01-31	2,926,818	-0.4%	443,133	6.60
2025-01-15	2,938,337	-0.5%	373,470	7.87
2024-12-31	2,954,372	+0.8%	486,155	6.08
2024-12-13	2,931,664	+6.5%	473,088	6.20
2024-11-29	2,753,758	+5.1%	693,806	3.97
2024-11-15	2,620,517	-6.4%	726,232	3.61
2024-10-31	2,800,492	-10.5%	246,978	11.34

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of AGEN volume is 61.6%, up 5.1 points over the last five sessions. Over the last 30 readings it ranged from 38.9% (28 October 2026) to 76.7% (19 October 2026). The latest reading is in line with the 30-session average of 62.1%, on 234K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	144K	234K	61.6%	0
2026-10-30	104K	180K	58.0%	20
2026-10-29	105K	212K	49.6%	760
2026-10-28	113K	291K	38.9%	4
2026-10-27	197K	342K	57.7%	0
2026-10-26	155K	274K	56.5%	0
2026-10-23	158K	211K	74.8%	0
2026-10-22	145K	222K	65.5%	0
2026-10-21	164K	256K	64.0%	0
2026-10-20	237K	342K	69.2%	0
2026-10-19	172K	225K	76.7%	26,394
2026-10-16	237K	431K	55.0%	3,984
2026-10-15	303K	397K	76.3%	9,600
2026-10-14	313K	440K	71.1%	0
2026-10-13	304K	509K	59.8%	3,132
2026-10-12	215K	296K	72.7%	0
2026-10-09	202K	309K	65.4%	0
2026-10-08	311K	408K	76.1%	549
2026-10-07	408K	596K	68.4%	34,715
2026-10-06	379K	688K	55.1%	29,725
2026-10-05	254K	388K	65.6%	711
2026-10-02	262K	491K	53.4%	19,375
2026-10-01	442K	949K	46.6%	34,716
2026-09-30	367K	613K	59.9%	1,402
2026-09-29	434K	709K	61.2%	622
2026-09-28	800K	1.3M	61.7%	550
2026-09-25	196K	310K	63.3%	0
2026-09-24	166K	304K	54.4%	0
2026-09-23	190K	304K	62.7%	3,400
2026-09-22	270K	444K	60.9%	18

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 23 September 2026, the fails-to-deliver balance in AGEN is 23 shares, down 85 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (19 August 2026) to 76,974 shares (20 July 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-09-23	23	$8.70	$200
2026-09-22	108	$8.33	$900
2026-09-21	69	$7.85	$542
2026-09-18	22	$7.22	$159
2026-09-11	12,465	$6.89	$86K
2026-09-04	218	$8.24	$2K
2026-09-03	325	$8.09	$3K
2026-09-02	340	$7.99	$3K
2026-08-31	8,496	$7.66	$65K
2026-08-27	37	$8.25	$305
2026-08-25	1	$7.67	$8
2026-08-24	6,421	$8.09	$52K
2026-08-21	55	$7.49	$412
2026-08-20	2,065	$8.26	$17K
2026-08-19	1	$7.53	$8
2026-08-14	7,089	$7.00	$50K
2026-08-11	2,015	$7.00	$14K
2026-08-07	47	$7.49	$352
2026-08-04	12,530	$7.82	$98K
2026-08-03	8,270	$7.50	$62K
2026-07-30	24,429	$6.63	$162K
2026-07-29	18	$6.60	$119
2026-07-27	2	$5.98	$12
2026-07-24	15,958	$6.19	$99K
2026-07-23	5,346	$5.53	$30K
2026-07-22	18,028	$5.58	$101K
2026-07-20	76,974	$5.01	$386K
2026-07-17	912	$5.00	$5K
2026-07-15	798	$5.08	$4K
2026-07-14	20,296	$6.12	$124K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for AGEN in the last 90 days. The most recent filings are listed below. Latest filing: HARRISON THOMAS L (Director) on 2026-10-01.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-10-01	HARRISON THOMAS L	Director	Grant	4K	$6.89	$31K	52K
2026-07-10	ARMEN GARO H	See Remarks	Grant	5K	$3.35	$16K	371K
2026-07-01	HARRISON THOMAS L	Director	Grant	9K	$3.58	$31K	48K
2026-06-26	ARMEN GARO H	See Remarks	Grant	5K	$3.03	$16K	366K
2026-06-12	ARMEN GARO H	See Remarks	Grant	5K	$3.30	$16K	361K
2026-05-29	ARMEN GARO H	See Remarks	Grant	5K	$3.50	$16K	356K
2026-05-15	ARMEN GARO H	See Remarks	Grant	5K	$3.58	$16K	351K
2026-05-01	ARMEN GARO H	See Remarks	Grant	4K	$3.84	$16K	347K
2026-04-17	ARMEN GARO H	See Remarks	Grant	3K	$4.79	$16K	343K
2026-04-03	ARMEN GARO H	See Remarks	Grant	5K	$3.33	$15K	339K
2026-04-01	HARRISON THOMAS L	Director	Grant	9K	$3.32	$31K	39K
2026-03-20	ARMEN GARO H	See Remarks	Grant	4K	$3.71	$15K	335K
2026-03-06	ARMEN GARO H	See Remarks	Grant	5K	$2.96	$15K	331K
2026-02-20	ARMEN GARO H	See Remarks	Grant	5K	$3.06	$15K	326K
2026-02-06	ARMEN GARO H	See Remarks	Grant	5K	$2.94	$15K	321K
2026-01-23	ARMEN GARO H	See Remarks	Grant	5K	$3.24	$15K	316K
2026-01-09	ARMEN GARO H	See Remarks	Grant	4K	$3.91	$15K	311K
2026-01-02	HARRISON THOMAS L	Director	Grant	8K	$3.98	$31K	30K
2025-12-26	ARMEN GARO H	See Remarks	Grant	5K	$3.31	$16K	307K
2025-12-12	ARMEN GARO H	See Remarks	Grant	4K	$3.79	$16K	302K
2025-11-28	ARMEN GARO H	See Remarks	Grant	4K	$4.56	$16K	298K
2025-11-14	ARMEN GARO H	See Remarks	Grant	4K	$4.34	$16K	294K
2025-10-31	ARMEN GARO H	See Remarks	Grant	4K	$3.97	$16K	291K
2025-10-17	ARMEN GARO H	See Remarks	Grant	4K	$3.88	$16K	287K
2025-10-03	ARMEN GARO H	See Remarks	Grant	4K	$4.14	$16K	282K
2025-10-01	HARRISON THOMAS L	Director	Grant	6K	$5.01	$29K	22K
2025-09-19	ARMEN GARO H	See Remarks	Grant	4K	$4.38	$16K	278K
2025-09-05	ARMEN GARO H	See Remarks	Grant	4K	$4.33	$16K	275K
2025-08-22	ARMEN GARO H	See Remarks	Grant	4K	$4.52	$16K	271K
2025-08-08	ARMEN GARO H	See Remarks	Grant	3K	$4.80	$16K	267K
2025-07-25	ARMEN GARO H	See Remarks	Grant	3K	$5.96	$16K	264K
2025-07-11	ARMEN GARO H	See Remarks	Grant	2K	$7.06	$16K	261K
2025-07-01	HARRISON THOMAS L	Director	Grant	7K	$3.46	$26K	16K
2025-06-27	ARMEN GARO H	See Remarks	Grant	3K	$4.76	$16K	259K
2025-06-18	ARMEN GARO H	See Remarks	Grant	61K	$4.47	$274K	255K
2025-06-18	KLASKIN CHRISTINE M	PFO & PAO	Grant	16K	$4.47	$71K	23K
2025-06-18	O'Day Steven J	Chief Medical Officer	Grant	43K	$4.47	$194K	57K
2025-06-13	ARMEN GARO H	See Remarks	Grant	3K	$4.70	$16K	194K
2025-05-30	ARMEN GARO H	See Remarks	Grant	5K	$3.43	$16K	191K
2025-05-16	ARMEN GARO H	See Remarks	Grant	5K	$3.48	$16K	186K
2025-05-02	ARMEN GARO H	See Remarks	Grant	5K	$3.11	$16K	181K
2025-05-02	Buell Jennifer	Director	Grant	581	$3.11	$2K	20K
2025-04-18	ARMEN GARO H	See Remarks	Grant	8K	$2.08	$16K	176K
2025-04-18	Buell Jennifer	Director	Grant	869	$2.08	$2K	19K
2025-04-04	ARMEN GARO H	See Remarks	Grant	10K	$1.56	$16K	168K
2025-04-04	Buell Jennifer	Director	Grant	1K	$1.56	$2K	18K
2025-04-01	HARRISON THOMAS L	Director	Grant	9K	$2.88	$26K	9K
2025-03-21	ARMEN GARO H	See Remarks	Grant	9K	$1.61	$15K	158K
2025-03-21	Buell Jennifer	Director	Grant	1K	$1.61	$2K	17K
2025-03-07	ARMEN GARO H	See Remarks	Grant	6K	$2.35	$15K	148K
2025-03-07	Buell Jennifer	Director	Grant	409	$2.35	$961	16K
2025-02-21	ARMEN GARO H	See Remarks	Grant	4K	$3.32	$15K	142K
2025-02-21	Buell Jennifer	Director	Grant	626	$3.32	$2K	15K
2025-02-21	Buell Jennifer	Director	Grant	545	$3.32	$2K	15K
2025-02-07	ARMEN GARO H	See Remarks	Grant	4K	$3.50	$15K	138K
2025-02-07	Buell Jennifer	Director	Grant	516	$3.50	$2K	15K
2025-01-24	ARMEN GARO H	See Remarks	Grant	4K	$3.57	$15K	133K
2025-01-24	Buell Jennifer	Director	Grant	776	$3.57	$3K	14K
2025-01-24	Buell Jennifer	Director	Tax withholding	270	$3.57	$964	14K
2025-01-10	ARMEN GARO H	See Remarks	Grant	5K	$3.12	$15K	129K
2024-12-27	ARMEN GARO H	See Remarks	Grant	6K	$2.75	$16K	124K
2024-12-13	ARMEN GARO H	See Remarks	Grant	5K	$3.05	$16K	118K
2024-11-29	ARMEN GARO H	See Remarks	Grant	5K	$3.42	$16K	113K
2024-11-15	ARMEN GARO H	See Remarks	Grant	6K	$2.72	$16K	108K
2024-11-01	ARMEN GARO H	See Remarks	Grant	4K	$4.05	$17K	102K
2024-10-18	ARMEN GARO H	See Remarks	Grant	4K	$4.62	$16K	98K
2024-10-04	ARMEN GARO H	See Remarks	Grant	3K	$4.87	$16K	95K
2024-09-20	ARMEN GARO H	See Remarks	Grant	3K	$5.84	$16K	91K
2024-09-06	ARMEN GARO H	See Remarks	Grant	3K	$4.95	$16K	89K
2024-08-23	ARMEN GARO H	See Remarks	Grant	3K	$5.47	$16K	85K
2024-08-09	ARMEN GARO H	See Remarks	Grant	3K	$5.09	$16K	82K
2024-07-26	ARMEN GARO H	See Remarks	Grant	2K	$6.56	$16K	79K
2024-07-12	ARMEN GARO H	See Remarks	Grant	1K	$15.60	$16K	77K
2024-06-28	ARMEN GARO H	See Remarks	Grant	973	$16.75	$16K	76K
2024-06-14	ARMEN GARO H	See Remarks	Grant	1K	$15.46	$16K	75K
2024-05-31	ARMEN GARO H	See Remarks	Grant	1K	$15.69	$16K	74K
2024-05-17	ARMEN GARO H	See Remarks	Grant	2K	$10.86	$16K	73K
2024-05-03	ARMEN GARO H	See Remarks	Grant	1K	$13.07	$16K	71K
2024-04-19	ARMEN GARO H	See Remarks	Grant	3K	$5.31	$16K	70K
2024-04-05	ARMEN GARO H	See Remarks	Grant	33K	$0.50	$16K	1.3M
2024-03-22	ARMEN GARO H	See Remarks	Grant	27K	$0.55	$15K	1.3M
2024-03-08	ARMEN GARO H	See Remarks	Grant	22K	$0.67	$15K	1.3M
2024-02-23	ARMEN GARO H	See Remarks	Grant	22K	$0.68	$15K	1.3M
2024-02-15	ARMEN GARO H	See Remarks	Buy	500K	$0.65	$325K	626K
2024-02-09	ARMEN GARO H	See Remarks	Grant	20K	$0.75	$15K	1.2M
2024-01-26	ARMEN GARO H	See Remarks	Grant	22K	$0.66	$15K	1.2M
2024-01-12	ARMEN GARO H	See Remarks	Grant	23K	$0.64	$15K	1.4M
2023-12-29	ARMEN GARO H	See Remarks	Grant	23K	$0.83	$19K	1.4M
2023-12-15	ARMEN GARO H	See Remarks	Grant	23K	$0.69	$16K	1.4M
2023-12-01	ARMEN GARO H	See Remarks	Grant	21K	$0.78	$16K	1.4M
2023-11-17	ARMEN GARO H	See Remarks	Grant	24K	$0.69	$16K	1.4M
2023-11-15	WIINBERG ULF	Director	Buy	25K	$0.76	$19K	124K
2023-11-03	ARMEN GARO H	See Remarks	Grant	19K	$0.84	$16K	1.3M
2023-10-20	ARMEN GARO H	See Remarks	Grant	18K	$0.89	$16K	1.3M
2023-10-06	ARMEN GARO H	See Remarks	Grant	15K	$1.06	$16K	1.3M
2023-09-22	ARMEN GARO H	See Remarks	Grant	14K	$1.18	$16K	1.3M
2023-09-08	ARMEN GARO H	See Remarks	Grant	13K	$1.23	$16K	1.3M
2023-01-05	O'Day Steven J	Chief Medical Officer	Grant	109K	$2.45	$268K	272K
2023-01-05	KLASKIN CHRISTINE M	PFO & PAO	Grant	31K	$2.45	$77K	154K
2023-01-05	ARMEN GARO H	Chairman and CEO	Grant	241K	$2.45	$591K	1.2M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

13 holders report 5% or more of AGEN in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is Raymond Debbane at 10.0% of the class (4,533,755 shares), filed 2026-07-17 for an event on 2026-07-13.

Filed	Form	Holder	Shares	Of class	Event
2026-07-27	13G	BlackRock, Inc.parent holding company	2.5M	6.0%	2026-06-30
2026-07-20	13G	Peter Kolchinskyparent holding company, individual	4.3M	9.9%	2026-07-13
2026-07-20	13G	Rajeev Shahparent holding company, individual	4.3M	9.9%	2026-07-13
2026-07-20	13G	RA Capital Healthcare Fund, L.P.partnership	4.3M	9.9%	2026-07-13
2026-07-20	13G	RA Capital Management, L.P.investment adviser, partnership	4.3M	9.9%	2026-07-13
2026-07-17	13G	Raymond Debbaneindividual	4.5M	10.0%	2026-07-13
2026-07-17	13G	Invus Public Equities, L.P.partnership	4.0M	8.8%	2026-07-13
2026-07-17	13G	Invus Public Equities Advisors, LLCother entity	4.0M	8.8%	2026-07-13
2026-07-17	13G	Invus Global Management, LLCother entity	4.0M	8.8%	2026-07-13
2026-07-17	13G	Siren, L.L.C.other entity	4.0M	8.8%	2026-07-13
2026-07-17	13G	Avicenna Life Sci Master Fund LPpartnership	562K	1.3%	2026-07-13
2026-07-17	13G	Avicenna Life Sci Master GP LLCother entity	562K	1.3%	2026-07-13
2026-07-17	13G	Ulys, L.L.C.other entity	562K	1.3%	2026-07-13
2026-03-26	13G/Ano. 6	The Vanguard Groupinvestment adviser	0	0.0%	2026-03-13
2026-01-23	13D	ZYNEXT VENTURES USA LLCother entity	2.1M	5.9%	2026-01-15
2026-01-23	13D	ZYNEXT VENTURES PTE LTDparent holding company, other entity	2.1M	5.9%	2026-01-15
2026-01-23	13D	ZYDUS LIFESCIENCES LTDparent holding company, other entity	2.1M	5.9%	2026-01-15

13F holders

Tracked managers holding AGEN at their latest 13F. JSON

2 of the 30 tracked managers held AGEN at their latest 13F, $1.0M in total at quarter-end prices. Renaissance Technologies is the largest at $699K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 2 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Renaissance Technologies	2026-06-30	228K	$699K	0.00%	-57K
Two Sigma Investments	2026-06-30	99K	$302K	0.00%	-72K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Agenus in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Agenus (AGEN), SEC CIK 1098972, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-23.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-27.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
Company record: EDGAR filing index for CIK 1098972Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as biological products, (no diagnostic substances)

Other company pages

Datasets

Frequently Asked Questions

How much of AGEN is sold short?

7,002,898 shares were held short at the 2026-10-15 settlement, 6.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is AGEN's daily short volume?

On 2026-11-02, 144,250 of the 234,098 AGEN shares reported to FINRA were sold short, 61.6% of the day's reported volume. Short volume is a flow for one day, not a position.

Does AGEN have fails to deliver?

The SEC's latest file shows 23 AGEN shares failed to deliver at settlement 2026-09-23. Fails are reported per settlement date and published twice a month with a lag.

Are AGEN insiders buying or selling?

No open-market insider trades were reported for AGEN in the last 90 days. The most recent filings are listed below. Latest filing: HARRISON THOMAS L (Director) on 2026-10-01.

Who owns 5% or more of AGEN?

Which tracked 13F managers own AGEN?

2 of the 30 tracked 13F managers held AGEN shares at their latest filing, $1.0M in all. The largest: Renaissance Technologies (228K shares, $699K), Two Sigma Investments (99K shares, $302K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.